A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
about
The CRISPR/Cas Genome-Editing Tool: Application in Improvement of CropsAdvanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the BrainBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogationApplications of CRISPR-Cas systems in neuroscienceA new age in functional genomics using CRISPR/Cas9 in arrayed library screeningEnabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewInvestigating neuronal function with optically controllable proteinsOff-target Effects in CRISPR/Cas9-mediated Genome EngineeringWireless Optofluidic Systems for Programmable In Vivo Pharmacology and OptogeneticsCRISPR-Cas9: from Genome Editing to Cancer ResearchCRISPR-Mediated Epigenome EditingEditing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and PlasticityAddressing biological uncertainties in engineering gene circuitsAn open-hardware platform for optogenetics and photobiologyCRISPR/Cas9: Transcending the Reality of Genome Editing.Complex transcriptional modulation with orthogonal and inducible dCas9 regulators.Genetic and epigenetic control of gene expression by CRISPR-Cas systems.Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.Genetic engineering: Chemical control for CRISPR editing.Optical Control of CRISPR/Cas9 Gene Editing.Precision cancer mouse models through genome editing with CRISPR-Cas9.Photoactivatable CRISPR-Cas9 for optogenetic genome editing.Conditional Control of CRISPR/Cas9 Function.Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors.Directing cellular information flow via CRISPR signal conductors.A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing.Application of CRISPR/Cas9 for biomedical discoveries.Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activatorsReactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Targeted genome regulation via synthetic programmable transcriptional regulators.Craniofacial Wound Healing with Photobiomodulation Therapy: New Insights and Current Challenges.Light-Patterned RNA Interference of 3D-Cultured Human Embryonic Stem Cells.Optogenetic Inhibitor of the Transcription Factor CREBA general strategy to construct small molecule biosensors in eukaryotes.Synthetic dual-input mammalian genetic circuits enable tunable and stringent transcription control by chemical and light.Optimized second-generation CRY2-CIB dimerizers and photoactivatable Cre recombinase.Editing the epigenome: technologies for programmable transcription and epigenetic modulation.Optimization of genome editing through CRISPR-Cas9 engineering
P2860
Q26752469-2BA03CBB-8E6B-41DB-A94A-34B4471E918CQ26770355-F46A6154-A03E-41E0-B9BF-8916CEA90888Q26775746-DB7012C6-C1AB-4F61-AA4F-34F1292EEB58Q26776515-F95A44F9-30E0-4677-B51F-9E7F914A381AQ26781135-9715A5EF-3F04-47A8-842C-EF1A82F8C72BQ26782747-2580D0EA-B29F-43F4-98B7-7C469B1D34F1Q26782876-00DD3A5F-3AC9-4CC3-925B-F2442D0A79D8Q26800227-F73A94EB-F891-4765-BA0B-902A0D8BCADDQ26859390-1B859CE0-21F6-492D-8170-496EDBD9557CQ27322457-A52609C3-16EE-42E7-B800-4B369F000B6DQ28066263-17ED64E8-7519-44E2-B5C6-7CE470E928A0Q28075872-4D20E0E4-B831-4B5C-A19A-3FDC34B2F44AQ28075883-E9ED9802-3B7B-4C08-8DA3-04C4F7F1ACD0Q28834528-637A9608-95F0-4F38-8C90-4D066D801EA6Q30827603-CAC328DC-B567-4BF4-AC9E-96189BF69BEDQ33632925-7AF28AFE-A0B8-4102-B67B-3F2DCAF1631FQ33704483-1EA9F78D-588E-42BF-9A7D-FF0D6F2FAB4FQ33777855-A24C47EF-07A9-4892-B339-F41F4A45E575Q34043681-DF9E4E40-E77B-47D5-93FA-5736CAA74DCDQ34047634-2E4F63D4-F021-48F8-AC1D-D51EB51A216CQ34473380-5DE4C130-BE47-43CB-B019-0673A129DAAEQ34480103-55FA6C56-7D98-4162-B4FA-CBCD3C64F11FQ34480785-6DA56E71-A9E1-40C7-ADD8-D9953B444E0FQ34519053-BE9F2203-FC2C-4BB3-929C-E36B1D2801B0Q34538256-1F898DB8-FAEA-46C0-9107-A6B6906786EFQ34539432-59BD59A9-D1E8-4C91-9ADE-C469009A611BQ34540074-1F8469C6-0B94-4AC3-80CA-1954F8B4BCA1Q34671188-D5823A22-5BB7-4E63-BA27-2E9EC7EFBB4FQ35871626-969CDED9-E7A8-4475-85FF-D0D127EC0DF7Q35876055-48D87F21-36C5-452E-8B4F-827E804AE9C6Q35942658-F4FFD855-5D73-44EF-A5D2-FD213F49394BQ35993731-753E9454-F9ED-477E-8978-AC32121AEAECQ36012723-52E72E12-53B3-47BA-A0BD-152167DEC661Q36175935-9850EAE7-FE3A-4A9E-82BE-300FC0ACD5A8Q36307757-D90AE680-3850-4A1E-BB4B-B34CA530449FQ36539758-A5703B79-7844-4A0A-9A6F-B83CE150B454Q36775481-6AA9573F-07F6-4834-A115-3A5DF266274FQ36913498-D6602B61-C484-4B9B-B2E4-3A95CD9B0C10Q37042113-6A4D67BC-019A-4293-B3BC-93FE9840E498Q37052485-468784B8-92CB-404F-8207-8C67C7EC89CF
P2860
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@ast
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@en
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@nl
type
label
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@ast
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@en
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@nl
prefLabel
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@ast
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@en
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@nl
P2860
P356
P1476
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
@en
P2093
Charles A Gersbach
Lauren R Polstein
P2860
P2888
P304
P356
10.1038/NCHEMBIO.1753
P577
2015-02-09T00:00:00Z